Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial
信迪利单抗诱导治疗在潜在可切除的 III 期非小细胞肺癌中的疗效和安全性(LungMate-009):一项开放标签的 II 期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103669
Ge, Tao; Zhang, Hongyi; Zhu, Xinsheng; Teng, Meixin; Zhou, Yifei; Wang, Suyu; Bian, Dongliang; Zhang, Lele; Hu, Haiyang; Guo, Qiji; Su, Jincheng; Hu, Shiqi; Yu, Huansha; Zhou, Yirui; Huang, Jie; Yang, Jie; Zhu, Yuming; Bao, Yi; Bao, Minwei; Hu, Xuefei; He, Wenxin; Zhang, Peng